JP2004530654A5 - - Google Patents

Download PDF

Info

Publication number
JP2004530654A5
JP2004530654A5 JP2002567138A JP2002567138A JP2004530654A5 JP 2004530654 A5 JP2004530654 A5 JP 2004530654A5 JP 2002567138 A JP2002567138 A JP 2002567138A JP 2002567138 A JP2002567138 A JP 2002567138A JP 2004530654 A5 JP2004530654 A5 JP 2004530654A5
Authority
JP
Japan
Prior art keywords
substituted
independently
alkyl
group
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002567138A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004530654A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/005156 external-priority patent/WO2002067761A2/en
Publication of JP2004530654A publication Critical patent/JP2004530654A/ja
Publication of JP2004530654A5 publication Critical patent/JP2004530654A5/ja
Pending legal-status Critical Current

Links

JP2002567138A 2001-02-23 2002-02-22 アテローム硬化症および脆弱性プラークを画像診断するための標識マクロファージスカベンジャー受容体拮抗薬 Pending JP2004530654A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27095401P 2001-02-23 2001-02-23
PCT/US2002/005156 WO2002067761A2 (en) 2001-02-23 2002-02-22 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque

Publications (2)

Publication Number Publication Date
JP2004530654A JP2004530654A (ja) 2004-10-07
JP2004530654A5 true JP2004530654A5 (https=) 2008-03-27

Family

ID=23033552

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002567138A Pending JP2004530654A (ja) 2001-02-23 2002-02-22 アテローム硬化症および脆弱性プラークを画像診断するための標識マクロファージスカベンジャー受容体拮抗薬

Country Status (12)

Country Link
US (2) US6869590B2 (https=)
EP (1) EP1377321A4 (https=)
JP (1) JP2004530654A (https=)
CN (1) CN1622832A (https=)
AU (1) AU2002254000A1 (https=)
BR (1) BR0207521A (https=)
CA (1) CA2438174A1 (https=)
CZ (1) CZ20032564A3 (https=)
HU (1) HUP0400027A3 (https=)
IL (1) IL157444A0 (https=)
MX (1) MXPA03007534A (https=)
WO (1) WO2002067761A2 (https=)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2445826C (en) 2001-05-02 2014-03-25 Purdue Research Foundation Treatment and diagnosis of macrophage mediated disease
US20030103995A1 (en) * 2001-06-04 2003-06-05 Hamblin Michael R. Detection and therapy of vulnerable plaque with photodynamic compounds
EP1443953A4 (en) * 2001-10-16 2005-11-23 Epix Pharm Inc IDENTIFICATION AND TREATMENT OF INTRAVASCULAR LESIONS
US8043602B2 (en) 2002-02-07 2011-10-25 Endocyte, Inc. Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology
US8043603B2 (en) 2002-02-07 2011-10-25 Endocyte, Inc. Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology
ES2347535T3 (es) 2002-11-05 2010-11-02 Ion Beam Applications S.A. Estabilizacion de composiciones acuosas de 2-fluoro-2-desoxi-d-glucosa marcada con el isotopo 18f con etanol.
US7018614B2 (en) * 2002-11-05 2006-03-28 Eastern Isotopes, Inc. Stabilization of radiopharmaceuticals labeled with 18-F
GB0228490D0 (en) * 2002-12-06 2003-01-08 Amersham Plc Novel imaging compounds
US7297154B2 (en) 2003-02-24 2007-11-20 Maxwell Sensors Inc. Optical apparatus for detecting and treating vulnerable plaque
US7153299B1 (en) 2003-02-24 2006-12-26 Maxwell Sensors Inc. Optical apparatus for detecting and treating vulnerable plaque
US7803352B2 (en) * 2003-03-07 2010-09-28 John Steele Fisher Method for continuous visualization of a blood clot or plaque in body lumen
DE602004017452D1 (de) 2003-05-30 2008-12-11 Purdue Research Foundation Diagnoseverfahren für atherosklerose
AU2004277981B2 (en) * 2003-10-03 2009-10-01 Merck & Co., Inc. Benzylether and benzylamino beta-secretase inhibitors for the treatment of Alzheimer's disease
EP1602931A1 (en) * 2004-06-03 2005-12-07 Universiteit Leiden SR-A antagonists
US20080206150A1 (en) * 2004-06-25 2008-08-28 The Regents Of The University Of California Nanoparticles for Imaging Atherosclerotic Plaque
US7575738B2 (en) 2004-08-13 2009-08-18 General Electric Company Heat shock protein as a targeting agent for endothelium-specific in vivo transduction
RU2007128036A (ru) * 2004-12-23 2009-01-27 Пердью Рисерч Фаундейшн (Us) Способ получения изображения позитронно-эмиссионной томографией
US20070009434A1 (en) 2005-07-05 2007-01-11 Low Philip S Imaging and therapeutic method using monocytes
US7874975B2 (en) * 2005-07-20 2011-01-25 Clear Vascular, Inc. Methods and compositions for treating luminal inflammatory disease
US8795633B2 (en) 2005-09-23 2014-08-05 Purdue Research Foundation Multiphoton in vivo flow cytometry method and device
US20070196282A1 (en) * 2006-02-21 2007-08-23 Siemens Medical Solutions Usa, Inc. Medical diagnostic ultrasound with temperature-dependent contrast agents
JP2010509570A (ja) 2006-11-03 2010-03-25 パーデュー・リサーチ・ファウンデーション エクスビボフローサイトメトリーの方法および装置
US8586595B2 (en) * 2007-02-07 2013-11-19 Purdue Research Foundation Positron emission tomography imaging method
CA2688308A1 (en) * 2007-05-25 2008-12-04 Purdue Research Foundation Method of imaging localized infections
RU2474435C2 (ru) * 2007-11-07 2013-02-10 Джи-И Хелткер БВ Стабилизация радиофармацевтических композиций
US8636670B2 (en) 2008-05-13 2014-01-28 The Invention Science Fund I, Llc Circulatory monitoring systems and methods
US9717896B2 (en) 2007-12-18 2017-08-01 Gearbox, Llc Treatment indications informed by a priori implant information
US20090287120A1 (en) 2007-12-18 2009-11-19 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US8361438B2 (en) 2008-01-08 2013-01-29 Lantheus Medical Imaging, Inc. N-alkoxyamide conjugates as imaging agents
US20100178245A1 (en) * 2009-01-13 2010-07-15 Arnsdorf Morton F Biocompatible Microbubbles to Deliver Radioactive Compounds to Tumors, Atherosclerotic Plaques, Joints and Other Targeted Sites
CA2803520C (en) 2009-07-08 2019-10-22 Lantheus Medical Imaging, Inc. N-alkoxyamide conjugates as imaging agents
US20150023873A1 (en) 2011-11-11 2015-01-22 Lantheus Medical Imaging, Inc. Evaluation of presence of and vulnerability to atrial fibrillation and other indications using matrix metalloproteinase-based imaging
DE112016001921B4 (de) 2015-06-09 2025-03-20 Cummins Filtration Ip, Inc. Kurbelgehäuseentlüftungssysteme, die rotierende Tropfenabscheidervorrichtungen verwenden
WO2019034500A1 (en) * 2017-08-15 2019-02-21 Koninklijke Philips N.V. INTRALUMINAL ULTRASONIC DEVICE WITH ADJUSTABLE FREQUENCY
WO2019118592A1 (en) * 2017-12-12 2019-06-20 Massachusetts Institute Of Technology Cell-permeable imaging sensors and uses thereof
KR102207372B1 (ko) * 2020-03-31 2021-01-27 재단법인 아산사회복지재단 방사성 의약품의 안정화제 및 이를 포함하는 방사성 의약 조성물
CN116473020B (zh) * 2022-11-18 2025-04-25 新乡医学院 一种Macrosialin基因缺失动脉粥样硬化小鼠模型的构建方法及其应用

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4577042A (en) * 1983-03-17 1986-03-18 California Institute Of Technology Homogeneous coordination compounds as oxidation catalysts
US4678667A (en) 1985-07-02 1987-07-07 501 Regents of the University of California Macrocyclic bifunctional chelating agents
US4752141A (en) 1985-10-25 1988-06-21 Luxtron Corporation Fiberoptic sensing of temperature and/or other physical parameters
EP0247156B1 (en) 1985-11-18 1993-06-23 Access Pharmaceuticals Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
MX174467B (es) 1986-01-23 1994-05-17 Squibb & Sons Inc 1,4,7-triscarboximetil-1,4,7,10-tetraazaciclodo decano substituido en 1 y compuestos analogos
US4885363A (en) 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
GB8603537D0 (en) 1986-02-13 1986-03-19 Parker D Conjugate compound
GB8719042D0 (en) 1987-08-12 1987-09-16 Parker D Conjugate compounds
AU630362B2 (en) 1988-05-25 1992-10-29 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Macrocyclic chelates & methods of use thereof
US4923985A (en) 1988-05-25 1990-05-08 The United States Of America As Represented By The Department Of Health & Human Services Process for synthesizing macrocyclic chelates
US5756065A (en) 1988-06-24 1998-05-26 The Dow Chemical Company Macrocyclic tetraazacyclododecane conjugates and their use as diagnostic and therapeutic agents
LU87403A1 (fr) 1988-12-06 1990-07-10 Oreal Procede de teinture de fibres keratiniques avec un hydroxyindole,associe a un derive quinonique
EP0382583B1 (en) 1989-02-10 1996-01-17 Celltech Therapeutics Limited Aza macrocycles and processes for their preparation
US5364613A (en) 1989-04-07 1994-11-15 Sieving Paul F Polychelants containing macrocyclic chelant moieties
US5914095A (en) 1989-04-07 1999-06-22 Salutar, Inc. Polychelants containg amide bonds
US4986671A (en) 1989-04-12 1991-01-22 Luxtron Corporation Three-parameter optical fiber sensor and system
US5087440A (en) 1989-07-31 1992-02-11 Salutar, Inc. Heterocyclic derivatives of DTPA used for magnetic resonance imaging
AU7587091A (en) 1990-03-26 1991-10-21 United States of America, as represented by the Secretary, U.S. Department of Commerce, The A fonctionalized complexand
US5275594A (en) 1990-11-09 1994-01-04 C. R. Bard, Inc. Angioplasty system having means for identification of atherosclerotic plaque
EP0565930A1 (en) 1992-03-27 1993-10-20 Nihon Medi-Physics Co., Ltd. Tetraazacyclododecane tetraacetic acid derivatives and the use thereof as diagnostic agents
US5310535A (en) 1992-04-24 1994-05-10 The Dow Chemical Company Carboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies
US5744120A (en) 1993-03-30 1998-04-28 The Dupont Merick Pharmaceutical Company Ternary radiopharmaceutical complexes
US5428156A (en) 1993-04-02 1995-06-27 Associated Universities, Inc. Synthesis of macrocyclic polyaminocarboxylates and their use for preparing stable radiometal antibody immunoconjugates for therapy, spect and pet imaging
AU2194695A (en) 1994-03-28 1995-10-17 Regents Of The University Of California, The Method for preparing radionuclide-labeled chelating agent-ligand complexes
IT1283218B1 (it) 1996-03-08 1998-04-16 Bracco Spa Polichelanti, loro complessi con ioni metallici, loro preparazione e loro usi
US5879659A (en) 1996-03-13 1999-03-09 Dupont Pharmaceuticals Company Ternary radiopharmaceutical complexes
US5848367A (en) 1996-09-13 1998-12-08 Sony Corporation System and method for sharing a non-volatile memory element as a boot device
US6403054B1 (en) 1997-05-28 2002-06-11 Bristol-Myers Squibb Pharma Company Ternary ligand complexes useful as radiopharmaceuticals
WO1999007382A1 (en) 1997-08-06 1999-02-18 Smithkline Beecham Corporation Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases
CA2328457A1 (en) 1998-06-20 1999-12-29 Washington University Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
CA2338122A1 (en) 1998-07-20 2000-01-27 Smithkline Beecham Corporation Macrophage scavenger receptor antagonists
CA2339094A1 (en) 1998-07-30 2000-02-10 Robert G. Franz Macrophage scavenger receptor antagonists

Similar Documents

Publication Publication Date Title
JP2004530654A5 (https=)
US5428139A (en) Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals
CA1341373C (en) Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates
US5462725A (en) 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
HUT72649A (en) Tricyclopolyazamacrocyclophosphonic acids, complexes and derivatives thereof for use as contrast agents
Pearson et al. Thrombus imaging using technetium-99m-labeled high-potency GPIIb/IIIa receptor antagonists. Chemistry and initial biological studies
JPH10502931A (ja) ペプチド誘導の放射性核種キレート化剤
JP3795521B2 (ja) ペプチド−キレート化剤複合体
HUT53375A (en) Process for producing peptide derivatives
NO324560B1 (no) Kaskadepolymerkomplekser, fremgangsmate for fremstilling, samt farmasoytiske midler inneholdende disse
JP2004536889A (ja) 大環状金属錯体と生体分子との結合体並びにnmr診断及び放射性診断及び放射線治療における使用のための薬剤を製造するためのその使用
JPH02501141A (ja) テトラ‐アザ大環状化合物およびその金属錯体
JP3007415B2 (ja) ホスホネート部分と非ホスホネート部分との両者を有するmri用のポリアミノ常磁性キレート
KR100330794B1 (ko) 혈관질병진단제
NO880179L (no) Polymerkomplekser, fremgangsmaate for fremstilling av disse og farmasoeytiske midler inneholdende disse.
JP7771080B2 (ja) 医薬配合物
EP0755385B1 (en) Chelant compounds
JPH04225925A (ja) 金属キレート造影剤用賦形剤
CA2265945A1 (en) Labelled elastase inhibitors
JPH07502043A (ja) ビシクロポリアザ大環状ホスホン酸、結合体、造影剤及び製造
US20120077967A1 (en) Novel technetium and rhenium complexes
EP0741747A1 (en) Inhibitors of serine proteases, bearing a chelating group
JP4878119B2 (ja) エナンチオマー純粋な(4S,8S)−及び(4R,8R)−4−p−ニトロベンジル−8−メチル−3,6,9−トリアザ−3N,6N,9N−トリカルボキシメチル−1,11−ウンデカン二酸及びそれらの誘導体、それらの製造方法並びに医薬品の製造のためのそれらの使用
WO2013060793A1 (en) Bifunctional ligands for radiometals
WO1994026313A1 (en) Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates, processes for their preparation, and use as contrast agents